AI assistant
PRECISION BIOSCIENCES INC — Director's Dealing 2022
Apr 13, 2022
34491_dirs_2022-04-13_ba4ce30b-1570-4569-b2f2-1150a136c2b5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2022-04-11
Reporting Person: Buehler Kevin (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-04-11 | Stock Option (Right to Buy) | $2.85 | A | 8763 | Acquired | 2032-04-10 | Common Stock (8763) | Direct |
| 2022-04-11 | Restricted Stock Units | $ | A | 5701 | Acquired | Common Stock (5701) | Direct |
Footnotes
F1: The option vests in 12 substantially equal monthly installments following April 11, 2022, such that the option shall be fully vested on April 11, 2023, subject to the Reporting Person continuing in service through each such vesting date.
F2: The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of the Company's Common Stock.
F3: The RSUs shall be fully vested on the first anniversary of the grant date of such RSUs, subject to the Reporting Person continuing in service through each such vesting date.